Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
166.94
↓ 85% below average
Average (6y)
1146.33
Historical baseline
Range
High:7753.76
Low:0.00
CAGR
+45.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 166.94 | -97.8% |
| 2023 | 7753.76 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 67.92 | - |
| 2020 | 0.00 | -100.0% |
| 2019 | 17.84 | 0.0% |
| 2018 | 17.84 | - |